• Company
• K-made new anti-cancer drugs to unveil at conference
• by Son, Hyung-Min Sep 6, 2024 05:48am

• Company
• Padcev’s reimb complex due to considerations
• by Hwang, Byung-woo Sep 5, 2024 05:52am

• Company
• Will Imfinzi pass CDDC review with biliary tract cancer data
• by Moon, sung-ho Sep 5, 2024 05:52am

• Opinion
• [Reporter’s View] Vaccine sovereignty only during epidemics
• by Son, Hyung-Min Sep 5, 2024 05:51am

• Company
• New lymphoma drug 'Columvi' reapplies for reimbursement
• by Eo, Yun-Ho Sep 5, 2024 05:51am

• Company
• More treatment options for rheumatoid arthritis available
• by Hwang, Byung-woo Sep 5, 2024 05:51am

• Company
• J&J appoints Christian Rodseth as new Managing Director
• by Hwang, Byung-woo Sep 5, 2024 05:51am

• Policy
• ‘Policy support enabled the prompt approval of Envlo’
• by Lee, Hye-Kyung Sep 4, 2024 05:49am

• Company
• New drug Voranigo receives orphan drug designation in Korea
• by Eo, Yun-Ho Sep 4, 2024 05:49am

• Company
• Yuhan's investment in US subsidiary total KRW 27B over 5 yrs
• by Chon, Seung-Hyun Sep 4, 2024 05:48am